Cargando…
Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy
The outbreak of 2019 novel coronavirus (COVID-19) has caused serious threat to public health. Discovery of new anti-COVID-19 drugs is urgently needed. Fortunately, the crystal structure of COVID-19 3CL proteinase was recently resolved. The proteinase has been identified as a promising target for dru...
Autores principales: | Xu, Zhongren, Yang, Lixiang, Zhang, Xinghao, Zhang, Qiling, Yang, Zhibin, Liu, Yuanhao, Wei, Shuang, Liu, Wukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561382/ https://www.ncbi.nlm.nih.gov/pubmed/33134310 http://dx.doi.org/10.3389/fmolb.2020.556481 |
Ejemplares similares
-
Combination of structure-based virtual screening, molecular docking and molecular dynamics approaches for the discovery of anti-prion fibril flavonoids
por: Jheng, Cheng-Ping, et al.
Publicado: (2023) -
Validation of Deep Learning-Based DFCNN in Extremely Large-Scale Virtual Screening and Application in Trypsin I Protease Inhibitor Discovery
por: Zhang, Haiping, et al.
Publicado: (2022) -
Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
por: Abdusalam, Ashraf Ahmed Ali, et al.
Publicado: (2020) -
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022) -
Target-driven machine learning-enabled virtual screening (TAME-VS) platform for early-stage hit identification
por: Bian, Yuemin, et al.
Publicado: (2023)